European Commission signs first contract for purchase coronavirus vaccine

On August 27, the European Commission signed the first contract with AstraZeneca for the purchase of 300 million doses of coronavirus vaccine.

This was reported by the press service of the European Commission.

The contract will allow the purchase of coronavirus vaccine for all the EU member states, as well as the donation to low and middle income countries or the re-direction to other European countries.

The Commission clarified that through the contract, all member states will be able to purchase 300 million doses of the AstraZeneca vaccine, with an option for further 100 million doses, to be distributed on a population data basis.

The European Commission plans to sign similar agreements with four more vaccine manufacturers and has concluded successful exploratory talks with Sanofi-GSK, Johnson & Johnson, CureVac and Moderna.

The AstraZeneca coronavirus vaccine is already in large-scale Phase II / III clinical trials after promising results in Phase I / II safety and immunogenicity.

Read also: WHO head calls on to distribute coronavirus vaccine equitably across the globe.